Several ubiquitin E3 ligases including FBXO38, KLHL22 and c-Cbl have been reported to promote PD-1 ubiquitination and subsequent degradation21–23, leading to the enhanced anti-tumor response of T cells. This evidence concerns the gene PDCD1 and neoplasm.